Palacios P, Santibanez A, Aguirre-Munoz F, Gutierrez-Vera C, Nino de Zepeda-Carrizo V, Gongora-Pimentel M
Front Immunol. 2025; 16:1505883.
PMID: 40040714
PMC: 11876049.
DOI: 10.3389/fimmu.2025.1505883.
Evans L, Barral P
Mol Immunol. 2024; 170:1-8.
PMID: 38579449
PMC: 11481681.
DOI: 10.1016/j.molimm.2024.03.011.
Brailey P, Evans L, Lopez-Rodriguez J, Sinadinos A, Tyrrel V, Kelly G
Nat Commun. 2022; 13(1):6723.
PMID: 36344546
PMC: 9640663.
DOI: 10.1038/s41467-022-34532-x.
Ververs F, Engelen S, Nuboer R, Vastert B, van der Ent C, Vant Land B
Sci Rep. 2021; 11(1):20082.
PMID: 34635725
PMC: 8505552.
DOI: 10.1038/s41598-021-99580-7.
Giussani P, Prinetti A, Tringali C
Int J Mol Sci. 2021; 22(12).
PMID: 34204326
PMC: 8234743.
DOI: 10.3390/ijms22126492.
Hepatocellular cancer-derived alpha fetoprotein uptake reduces CD1 molecules on monocyte-derived dendritic cells.
Li C, Song B, Santos P, Butterfield L
Cell Immunol. 2018; 335:59-67.
PMID: 30392891
PMC: 6368446.
DOI: 10.1016/j.cellimm.2018.10.011.
Mrp1 is involved in lipid presentation and iNKT cell activation by Streptococcus pneumoniae.
Chandra S, Gray J, Kiosses W, Khurana A, Hitomi K, Crosby C
Nat Commun. 2018; 9(1):4279.
PMID: 30323255
PMC: 6189046.
DOI: 10.1038/s41467-018-06646-8.
Immunometabolic Activation of Invariant Natural Killer T Cells.
Ververs F, Kalkhoven E, Vant Land B, Boes M, Schipper H
Front Immunol. 2018; 9:1192.
PMID: 29892305
PMC: 5985373.
DOI: 10.3389/fimmu.2018.01192.
ATP Binding Cassette Transporter ABCA7 Regulates NKT Cell Development and Function by Controlling CD1d Expression and Lipid Raft Content.
Nowyhed H, Chandra S, Kiosses W, Marcovecchio P, Andary F, Zhao M
Sci Rep. 2017; 7:40273.
PMID: 28091533
PMC: 5238393.
DOI: 10.1038/srep40273.
Bcl-xL regulates CD1d-mediated antigen presentation to NKT cells by altering CD1d trafficking through the endocytic pathway.
Subrahmanyam P, Carey G, Webb T
J Immunol. 2014; 193(5):2096-105.
PMID: 25070854
PMC: 4169674.
DOI: 10.4049/jimmunol.1400155.
Interplay of cytoskeletal activity and lipid phase stability in dynamic protein recruitment and clustering.
Gomez-Llobregat J, Buceta J, Reigada R
Sci Rep. 2013; 3:2608.
PMID: 24018870
PMC: 3767946.
DOI: 10.1038/srep02608.
A Thr/Ser dual residue motif in the cytoplasmic tail of human CD1d is important for the down-regulation of antigen presentation following a herpes simplex virus 1 infection.
Liu J, Glosson N, Du W, Gervay-Hague J, Brutkiewicz R
Immunology. 2013; 140(2):191-201.
PMID: 23710894
PMC: 3784165.
DOI: 10.1111/imm.12127.
Design, synthesis, and functional activity of labeled CD1d glycolipid agonists.
Jervis P, Polzella P, Wojno J, Jukes J, Ghadbane H, Garcia Diaz Y
Bioconjug Chem. 2013; 24(4):586-94.
PMID: 23458425
PMC: 3630740.
DOI: 10.1021/bc300556e.
Regulation of the actin cytoskeleton by Rho kinase controls antigen presentation by CD1d.
Gallo R, Khan M, Shi J, Kapur R, Wei L, Bailey J
J Immunol. 2012; 189(4):1689-98.
PMID: 22798677
PMC: 3411863.
DOI: 10.4049/jimmunol.1101484.
Towards multivalent CD1d ligands: synthesis and biological activity of homodimeric α-galactosyl ceramide analogues.
Jervis P, Moulis M, Jukes J, Ghadbane H, Cox L, Cerundolo V
Carbohydr Res. 2012; 356:152-62.
PMID: 22445102
PMC: 3413882.
DOI: 10.1016/j.carres.2012.02.034.
The split personality of NKT cells in malignancy, autoimmune and allergic disorders.
Subleski J, Jiang Q, Weiss J, Wiltrout R
Immunotherapy. 2011; 3(10):1167-84.
PMID: 21995570
PMC: 3230042.
DOI: 10.2217/imt.11.117.
Stimulation of a shorter duration in the state of anergy by an invariant natural killer T cell agonist enhances its efficiency of protection from type 1 diabetes.
Tohn R, Blumenfeld H, Haeryfar S, Veerapen N, Besra G, Porcelli S
Clin Exp Immunol. 2011; 164(1):26-41.
PMID: 21361909
PMC: 3074214.
DOI: 10.1111/j.1365-2249.2011.04323.x.
Mouse and human iNKT cell agonist β-mannosylceramide reveals a distinct mechanism of tumor immunity.
OKonek J, Illarionov P, Stewart Khursigara D, Ambrosino E, Izhak L, Castillo 2nd B
J Clin Invest. 2011; 121(2):683-94.
PMID: 21245578
PMC: 3026717.
DOI: 10.1172/JCI42314.
Lipid and glycolipid antigens of CD1d-restricted natural killer T cells.
Venkataswamy M, Porcelli S
Semin Immunol. 2009; 22(2):68-78.
PMID: 19945296
PMC: 2837800.
DOI: 10.1016/j.smim.2009.10.003.
Alpha versus beta: are we on the way to resolve the mystery as to which is the endogenous ligand for natural killer T cells?.
Ilan Y
Clin Exp Immunol. 2009; 158(3):300-7.
PMID: 19793337
PMC: 2792826.
DOI: 10.1111/j.1365-2249.2009.04030.x.